Tranexamic acid (trans-4-aminomethyl cyclohexane carboxylic acid) is an inhibitor of fibrinolysis and thus has been used as a hemostatic agent for the treatment of severe hemorrhage. It is used in hemophiliac patients to prevent hemorrhage and to reduce the need for replacement of blood factors. Its most interesting use has been in the treatment of malignant ovarian tumors, to promote formation of fibrin caps to wall off and inhibit growth of the tumor. 1 The drug reduces postoperative blood losses and transfusion requirements in a number of types of surgery, with potential cost and tolerability advantages over aprotinin, and appears to reduce rates of mortality and urgent surgery in patients with upper gastrointestinal hemorrhage. Tranexamic acid reduces menstrual blood loss and is a possible alternative to surgery in menorrhagia, and has been used successfully to control bleeding in pregnancy. 2 Several methods have been reported for the determination of tranexamic acid in pharmaceutical formulations: these methods include spectrophotometry, [3] [4] [5] [6] colorimetry, 7 HPLC, [8] [9] [10] [11] liquid chromatography-tandem mass spectrometry, 12 atomic absorption spectrometry, 13 gas chromatography 14 and spectrofluorometry. 15 Most of these methods are laborious and costly. There is a need for a sensitive, rapid and reliable method for routine analysis of tranexamic acid in bulk and pharmaceutical preparations. An attempt has been made to use the reaction between tranexamic acid and ninhydrin reagent as a basis for spectrophotometric determination of tranexamic acid.
Experimental

Equipment
All spectrophotometric measurements were carried out using a spectrophotometer (U1100 Hitachi, Japan) with a silica glass cell of 1 cm thickness. Officially calibrated Pyrex glassware was used throughout this study.
Chemicals and reagents
All chemicals used were of analytical reagent grade. Tranexamic acid was supplied by Indus Pharma (Pvt.) Ltd., Karachi, Pakistan. The water used was doubly distilled.
Stock solution of tranexamic acid was prepared by dissolving 100 mg powder in 100 ml of water. Standard tranexamic acid solutions were prepared from the stock solution by appropriate dilution with water. A 0.2% ninhydrin (Merck) solution was prepared in methanol. A 1 M phosphate buffer solution of pH 8.0 was prepared by dissolving 13.61 g of potassium dihydrogen phosphate (Merck) in a 100 ml measuring flask and made up to volume with distilled water. The pH was adjusted with 1 M NaOH solution.
Proposed method
To different aliquots of tranexamic acid (3 -40 µg ml -1 ) in a heating tube, 1 ml of phosphate buffer (pH 8.0) and 2 ml of ninhydrin solution (0.2% in methanol) were added. The mixture was heated for 20 min at 90 ± 5˚C using paraffin oil. Then we cooled the mixture to room temperature and transferred it to a 10 ml measuring flask and made the volume up to mark with distilled water. Absorbance measurements were made at 565 nm against reagent blank.
Analysis of tranexamic acid in pharmaceutical formulations
Tranexamic acid formulations (capsules and injections) were purchased from the local market of Multan, Pakistan. Twenty capsules were accurately weighed and powdered (without shells). A portion equivalent to 100 mg of tranexamic acid was stirred with 60 ml of distilled water. The sample solution was filtered using Whatman filter paper #1. The residue was washed with distilled water. The filtrate and washings were diluted with distilled water to 1000 ml using a measuring flask. In this study, a simple, fast, accurate and sensitive spectrophotometric method has been developed for the determination of tranexamic acid in bulk and pharmaceutical preparations. The method is based on the reaction of ninhydrin with the primary amino group of tranexamic acid in the basic medium at pH 8.0. The reaction produces a bluish-purple color which absorbs maximally at 565 nm. Beer's law was obeyed in the range of 3 -40 µg ml To 1-ml of the sample solution in a heating tube, 1-ml of phosphate buffer (pH 8.0) and 2 ml of ninhydrin solution (0.2% in methanol) were added. We heated the mixture for 20 min at 90 ± 5˚C using paraffin oil. Then we cooled the mixture to room temperature and transferred it to a 10 ml measuring flask and made the volume up to mark with distilled water. Absorbance measurements were made at 565 nm against a sample blank.
For injection, an appropriate volume of sample (equivalent to 100 mg of tranexamic acid) was diluted to 1000 ml distilled water and analyzed for tranexamic acid using the procedure described for the capsules.
Results and Discussion
Ninhydrin reagent is used for the detection; quantitative estimation of amino acids and imino acids depends on the formation of Ruhemann's purple. 16 It has been reported that in alkaline medium ninhydrin is converted to ocarboxyphenylglyoxal which would reduce ninhydrin to 2-hydroxyindan-1,3-dione. 17, 18 Tranexamic acid contains a primary aliphatic amino group which reacts with ninhydrin reagent in the presence of phosphate buffer pH 8.0 via oxidation deamination of the primary amino group, followed by the condensation of the reduced ninhydrin.
This results in Ruhemann's purple product, which absorbs maximally at 565 nm. The possible mechanism of the reaction is given in the scheme. Based upon this reaction, a rapid, accurate, economical and easy spectrophotometric method has been developed for routine analysis of tranexamic acid in bulk and pharmaceutical formulations.
To optimize the reaction conditions, we thoroughly investigated different parameters such as pH, temperature, heating time, reagent concentration, color stability and measuring range. The reaction between tranexamic acid and ninhydrin took place in the basic medium using phosphate buffer (pH 8.0). No reaction was observed in the acidic and neutral media. A 1-ml volume of the phosphate buffer (pH 8.0) was found to be sufficient to maintain the pH of the system. The maximum color intensity of the system was observed after 20 min of heating at 90˚C using paraffin oil. The effect of ninhydrin concentration on the color development was investigated. It was found that 2 ml of 0.2% ninhydrin reagent solution produced maximum color intensity in the measuring range.
The color intensity of the system remained stable for up to 2 h which was considered to be sufficient time for an analytical chemist to carry out absorbance measurements. Beer's law was obeyed in the range of 3 -40 µg ml -1 . Optical characteristics and statistical data for the regression equation of the proposed method are given in Table 1 . More than 99% recovery of tranexamic acid was obtained in the presence of possible excipients in tranexamic acid formultations (Table 2) . A comparison of performance of the proposed method with already reported spectrophotometric procedures is given in Table 3 ; the results indicate that the newly developed method is more sensitive and rapid. Commercial formulations were successfully analyzed for tranexamic acid contents by the newly proposed method and by the reference method. 19 The results presented in Table 4 show that the methods are comparable statistically.
It may be concluded that the newly developed spectrophotometric method is highly sensitive, accurate, rapid, economical and easy for routine analysis of tranexamic acid in bulk and pharmaceutical preparations. Rec., % Ref. Table 3 Comparison of proposed method with existing spectrophotometric methods λ 
